Ortoma AB Series B (ORT-B) - Total Liabilities
Based on the latest financial reports, Ortoma AB Series B (ORT-B) has total liabilities worth Skr18.63 Million SEK (≈ $2.00 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. For the complete balance sheet picture, see Ortoma AB Series B (ORT-B) total assets.
Ortoma AB Series B - Total Liabilities Trend (2021–2025)
This chart illustrates how Ortoma AB Series B's total liabilities have evolved over time, based on quarterly financial data. See Ortoma AB Series B working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Ortoma AB Series B Competitors by Total Liabilities
The table below lists competitors of Ortoma AB Series B ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Asphere Innovations Public Company Limited
BK:AS
|
Thailand | ฿438.81 Million |
|
Senetas Corporation Ltd
AU:SEN
|
Australia | AU$16.74 Million |
|
Choice Development Inc
TW:9929
|
Taiwan | NT$998.37 Million |
|
Phenom Resources Corp
V:PHNM
|
Canada | CA$180.24K |
|
Taiwan Benefit Co
TWO:3379
|
Taiwan | NT$531.45 Million |
|
Mtag Group Berhad
KLSE:0213
|
Malaysia | RM10.61 Million |
|
CervoMed Inc.
NASDAQ:CRVO
|
USA | $3.03 Million |
|
Penguen Gida Sanayi AS
IS:PENGD
|
Turkey | TL2.54 Billion |
Liability Composition Analysis (2021–2025)
This chart breaks down Ortoma AB Series B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See ORT-B defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.19 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.13 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Ortoma AB Series B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Ortoma AB Series B (2021–2025)
The table below shows the annual total liabilities of Ortoma AB Series B from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr18.63 Million ≈ $2.00 Million |
-2.35% |
| 2024-12-31 | Skr19.07 Million ≈ $2.05 Million |
+1.48% |
| 2023-12-31 | Skr18.80 Million ≈ $2.02 Million |
-49.23% |
| 2022-12-31 | Skr37.02 Million ≈ $3.98 Million |
+836.96% |
| 2021-12-31 | Skr3.95 Million ≈ $425.22K |
-- |
About Ortoma AB Series B
Ortoma AB (publ) provides orthopedic surgical products in Sweden. It offers Ortoma Treatment Solution (OTS), an orthopedic digital, server-based integrated AI platform designed to optimize patient outcomes through surgical planning, precision surgical navigation, post-operative verification, and follow-up; OTS Plan, a software that processes and assists surgeons during pre-operative planning and … Read more